Literature DB >> 7436183

Homozygosity for hemochromatosis: clinical manifestations.

C Q Edwards, G E Cartwright, M H Skolnick, D B Amos.   

Abstract

We identified 35 homozygotes for hemochromatosis through pedigree studies. Thirteen were asymptomatic. Arthropathy was present in 20, hepatomegaly in 19, transaminasemia in 16, skin pigmentation in 15, splenomegaly in 14, cirrhosis in 14, hypogonadism in six, and diabetes in two. No homozygote was in congestive failure. Only one had the triad of hepatomegaly, hyperpigmentation, and diabetes. Serum iron was increased in 30 of 35, transferrin saturation was increased in all 35, serum ferritin in 23 of 32, urinary iron excretion after deferoxamine in 28 of 33, hepatic parenchymal cell stainable iron in 32 of 33, and hepatic iron in 27 of 27. Iron loading was 2.7 times greater in men than in women. No female had hepatic cirrhosis. Diagnosis of asymptomatic hemochromatosis is important because organ damage may be prevented by early therapy. Clinical diagnosis of early hemochromatosis is difficult. Persons with unexplained elevation of transferrin saturation should be studied for hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7436183     DOI: 10.7326/0003-4819-93-4-519

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Hypogonadotropic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement.

Authors:  K Siminoski; M D'Costa; P G Walfish
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

Review 2.  A diagnostic approach to hemochromatosis.

Authors:  Anthony S Tavill; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2006-08       Impact factor: 3.522

Review 3.  The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

Authors:  David S Goldberg; Michael B Fallon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-28       Impact factor: 11.382

4.  Screening for hemochromatosis?

Authors:  F A Lederle
Journal:  J Gen Intern Med       Date:  1989 Jan-Feb       Impact factor: 5.128

5.  The HLA linked iron loading gene in an Afrikaner population.

Authors:  T E Meyer; D Ballot; T H Bothwell; A Green; D P Derman; R D Baynes; T Jenkins; P L Jooste; E D du Toit; P J Jacobs
Journal:  J Med Genet       Date:  1987-06       Impact factor: 6.318

6.  HLA as a marker of the hemochromatosis gene in Sweden.

Authors:  B Ritter; J Säfwenberg; K S Olsson
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Idiopathic familial hemochromatosis: limited disease extent with prolonged survival and arthritis.

Authors:  J L De Greve; L A Verbruggen; D Schallier; B Van Camp
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

8.  The significance of haemochromatosis gene mutations in the general population: implications for screening.

Authors:  M J Burt; P M George; J D Upton; J A Collett; C M Frampton; T M Chapman; T A Walmsley; B A Chapman
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

9.  The H63D variant in the HFE gene predisposes to arthralgia, chondrocalcinosis and osteoarthritis.

Authors:  B Z Alizadeh; O T Njajou; J M W Hazes; A Hofman; P E Slagboom; H A P Pols; C M van Duijn
Journal:  Ann Rheum Dis       Date:  2007-02-06       Impact factor: 19.103

10.  The use of association data to identify family members at high risk for marker-linked diseases.

Authors:  W J Conte; J I Rotter
Journal:  Am J Hum Genet       Date:  1984-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.